HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianbing Wu Selected Research

Jianbing Wu Research Topics

Disease

22Neoplasms (Cancer)
03/2024 - 01/2013
21Hepatocellular Carcinoma (Hepatoma)
05/2024 - 01/2017
5Inflammation (Inflammations)
12/2023 - 06/2012
4Neoplasm Metastasis (Metastasis)
12/2023 - 01/2021
3Neuroinflammatory Diseases
12/2023 - 01/2022
3Triple Negative Breast Neoplasms
12/2023 - 09/2018
3Ischemic Stroke
12/2023 - 01/2022
3Melanoma (Melanoma, Malignant)
01/2020 - 05/2017
2Carcinogenesis
01/2023 - 01/2022
2Hypoxia (Hypoxemia)
12/2021 - 01/2021
1Glioma (Gliomas)
03/2024
1Echinococcosis (Hydatid Cysts)
12/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2023
1Weight Loss (Weight Reduction)
12/2023
1Cryptococcosis
10/2023
1Wounds and Injuries (Trauma)
03/2023
1Fatigue
07/2022
1Drug-Related Side Effects and Adverse Reactions
01/2022
1Edema (Dropsy)
01/2022
1Cognitive Dysfunction
01/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022
1Abdominal Pain (Pain, Abdominal)
01/2022
1Microsatellite Instability
01/2022
1Glaucoma
01/2022
1Neutropenia
01/2022
1Ocular Hypertension (Glaucoma, Suspect)
01/2022
1Cerebral Infarction
01/2022
1Ischemia
12/2021

Drug/Important Bio-Agent (IBA)

10Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2024 - 10/2016
7Sorafenib (BAY 43-9006)FDA Link
01/2023 - 01/2015
6Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2013
5Immune Checkpoint InhibitorsIBA
06/2023 - 01/2021
4lenvatinibIBA
05/2024 - 01/2022
4RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
4Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA
01/2022 - 01/2021
3Peptides (Polypeptides)IBA
12/2023 - 09/2019
3Nitric Oxide DonorsIBA
10/2023 - 05/2017
3regorafenibIBA
01/2023 - 01/2021
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2021
2bergaptolIBA
03/2024 - 01/2022
2Reducing AgentsIBA
12/2023 - 11/2020
2ProdrugsIBA
12/2023 - 10/2022
2Bevacizumab (Avastin)FDA Link
06/2023 - 01/2021
2Biosimilar PharmaceuticalsIBA
06/2023 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
10/2022 - 11/2020
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2022 - 01/2022
2MethyltransferasesIBA
01/2022 - 01/2022
2Therapeutic UsesIBA
01/2022 - 01/2021
2Long Noncoding RNAIBA
01/2022 - 01/2018
2diazeniumdiolateIBA
01/2018 - 10/2016
2Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2013
2Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 10/2016
1AntibodiesIBA
03/2024
1Immunoconjugates (Immunoconjugate)IBA
03/2024
1Cysteine (L-Cysteine)FDA Link
03/2024
1PlatinumIBA
12/2023
1Harmine (Telepathine)IBA
12/2023
1Carbolines (Beta-Carbolines)IBA
12/2023
1MicroRNAs (MicroRNA)IBA
12/2023
1LipopolysaccharidesIBA
12/2023
1citral (neral)IBA
12/2023
1baicalinIBA
10/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023
1echinacosideIBA
10/2023
1AzolesIBA
10/2023
1CollagenIBA
03/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2023
1ChemokinesIBA
01/2023
1Telmisartan (Micardis)FDA Link
12/2022
1Myelin Basic ProteinIBA
12/2022
1isoborneol (borneol)IBA
12/2022
1Neurofilament ProteinsIBA
12/2022
1EstersIBA
12/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1LigandsIBA
01/2022
1Lysine (L-Lysine)FDA Link
01/2022
1Ephrin-A5 (AL-1)IBA
01/2022
1K-115IBA
01/2022
1Ephrin-B1 (Ephrin B1)IBA
01/2022
1Ephrin-B3 (Ephrin B3)IBA
01/2022
13-n-butylphthalide (butylphthalide)IBA
01/2022
1Ephrin-A1 (Ephrin A1)IBA
01/2022
1EphrinsIBA
01/2022
1Neuroprotective AgentsIBA
01/2022
1Protein Kinases (Protein Kinase)IBA
01/2022
1Sulfhydryl Compounds (Thiols)IBA
12/2021
1Oxygen (Dioxygen)IBA
12/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1NitritesIBA
12/2021
1Liposomes (Liposome)IBA
03/2021
1Acrolein (Aqualin)IBA
03/2021
1Free RadicalsIBA
03/2021
1ParaffinIBA
01/2021
1sintilimabIBA
01/2021

Therapy/Procedure

7Therapeutics
10/2022 - 01/2015
4Immunotherapy
03/2024 - 01/2021
3Drug Therapy (Chemotherapy)
05/2024 - 01/2022
2Subcutaneous Injections
01/2021 - 10/2020
1Oral Administration
01/2022
1Topical Administration
01/2022